EdgarLookup

FIVE BELOW, INC — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that FIVE BELOW, INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
7.5%
Profit Margin
Net income ÷ revenue
7.3%
Return on Assets
Net income ÷ assets
1.25x
Debt-to-Equity
Total liabilities ÷ equity
+242.5%
Revenue Growth
Year over year

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $4.76B Mar 19, 2026
FY2024 Feb 1, 2025 $1.39B Mar 20, 2025
FY2024 Nov 2, 2024 $843.71M Mar 20, 2025
FY2024 Aug 3, 2024 $830.07M Mar 20, 2025
FY2024 May 4, 2024 $811.86M Mar 20, 2025
FY2024 Feb 3, 2024 $1.34B Mar 20, 2025
FY2024 Oct 28, 2023 $736.41M Mar 20, 2025
FY2024 Jul 29, 2023 $758.98M Mar 20, 2025
FY2024 Apr 29, 2023 $726.25M Mar 20, 2025
FY2023 Jan 28, 2023 $1.12B Mar 21, 2024

Revenue (Net Sales)

Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.

Fiscal Year Period End Value Filed
FY2018 Feb 2, 2019 $602.68M Mar 28, 2019
FY2018 Nov 3, 2018 $312.82M Mar 28, 2019
FY2018 Aug 4, 2018 $347.73M Mar 28, 2019
FY2018 May 5, 2018 $296.32M Mar 28, 2019
FY2018 Feb 3, 2018 $504.83M Mar 28, 2019
FY2018 Oct 28, 2017 $257.18M Mar 28, 2019
FY2018 Jul 29, 2017 $283.32M Mar 28, 2019
FY2018 Apr 29, 2017 $232.88M Mar 28, 2019
FY2016 Jan 28, 2017 $388.09M Mar 22, 2018
FY2016 Oct 29, 2016 $199.48M Mar 22, 2018

Gross Profit

Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.

Fiscal Year Period End Value Filed
FY2022 Jan 28, 2023 $452.40M Mar 16, 2023
FY2022 Oct 29, 2022 $207.81M Mar 16, 2023
FY2022 Jul 30, 2022 $228.51M Mar 16, 2023
FY2022 Jan 29, 2022 $396.89M Mar 16, 2023
FY2022 Oct 30, 2021 $202.36M Mar 16, 2023
FY2022 Jul 31, 2021 $230.32M Mar 16, 2023
FY2022 May 1, 2021 $200.87M Mar 16, 2023
FY2021 Jan 30, 2021 $340.93M Mar 30, 2022
FY2021 Oct 31, 2020 $151.10M Mar 30, 2022
FY2021 Aug 1, 2020 $139.84M Mar 30, 2022

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $358.64M Mar 19, 2026
FY2024 Feb 1, 2025 $187.46M Mar 20, 2025
FY2024 Nov 2, 2024 $1.69M Mar 20, 2025
FY2024 Aug 3, 2024 $33.00M Mar 20, 2025
FY2024 May 4, 2024 $31.47M Mar 20, 2025
FY2024 Feb 3, 2024 $202.20M Mar 20, 2025
FY2024 Oct 28, 2023 $14.59M Mar 20, 2025
FY2024 Jul 29, 2023 $46.84M Mar 20, 2025
FY2024 Apr 29, 2023 $37.48M Mar 20, 2025
FY2023 Jan 28, 2023 $171.32M Mar 21, 2024

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $457.40M Mar 19, 2026
FY2024 Feb 1, 2025 $246.76M Mar 20, 2025
FY2024 Nov 2, 2024 ($606.0K) Mar 20, 2025
FY2024 Aug 3, 2024 $41.51M Mar 20, 2025
FY2024 May 4, 2024 $36.15M Mar 20, 2025
FY2024 Feb 3, 2024 $268.44M Mar 20, 2025
FY2024 Oct 28, 2023 $16.12M Mar 20, 2025
FY2024 Jul 29, 2023 $58.59M Mar 20, 2025
FY2024 Apr 29, 2023 $42.41M Mar 20, 2025
FY2023 Jan 28, 2023 $225.77M Mar 21, 2024

SG&A Expense

Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $1.07B Mar 19, 2026
FY2025 Feb 1, 2025 $861.40M Mar 19, 2026
FY2025 Feb 3, 2024 $757.51M Mar 19, 2026
FY2024 Jan 28, 2023 $644.83M Mar 20, 2025
FY2023 Jan 29, 2022 $565.73M Mar 21, 2024
FY2022 Jan 30, 2021 $497.53M Mar 16, 2023
FY2021 Feb 1, 2020 $456.68M Mar 30, 2022
FY2020 Feb 2, 2019 $377.90M Mar 18, 2021
FY2019 Feb 3, 2018 $306.02M Mar 19, 2020
FY2018 Jan 28, 2017 $243.08M Mar 28, 2019

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $586.43M Mar 19, 2026
FY2025 Feb 1, 2025 $430.65M Mar 19, 2026
FY2025 Feb 3, 2024 $499.62M Mar 19, 2026
FY2024 Jan 28, 2023 $314.93M Mar 20, 2025
FY2023 Jan 29, 2022 $327.91M Mar 21, 2024
FY2022 Jan 30, 2021 $365.97M Mar 16, 2023
FY2021 Feb 1, 2020 $187.03M Mar 30, 2022
FY2020 Feb 2, 2019 $184.13M Mar 18, 2021
FY2019 Feb 3, 2018 $167.38M Mar 19, 2020

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $174.74M Mar 19, 2026
FY2025 Feb 1, 2025 $323.99M Mar 19, 2026
FY2025 Feb 3, 2024 $335.05M Mar 19, 2026
FY2024 Jan 28, 2023 $251.95M Mar 20, 2025
FY2023 Jan 29, 2022 $288.17M Mar 21, 2024
FY2022 Jan 30, 2021 $200.19M Mar 16, 2023
FY2021 Feb 1, 2020 $212.30M Mar 30, 2022
FY2020 Feb 2, 2019 $113.72M Mar 18, 2021
FY2019 Feb 3, 2018 $67.80M Mar 19, 2020
FY2018 Jan 28, 2017 $44.79M Mar 28, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $4.94B Mar 19, 2026
FY2025 Feb 1, 2025 $4.34B Mar 19, 2026
FY2024 Feb 3, 2024 $3.87B Mar 20, 2025
FY2023 Jan 28, 2023 $3.32B Mar 21, 2024
FY2022 Jan 29, 2022 $2.88B Mar 16, 2023
FY2021 Jan 30, 2021 $2.31B Mar 30, 2022
FY2020 Feb 1, 2020 $1.96B Mar 18, 2021
FY2019 Feb 3, 2019 $1.57B Mar 19, 2020
FY2019 Feb 2, 2019 $952.26M Mar 19, 2020
FY2018 Feb 3, 2018 $695.71M Mar 28, 2019

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $2.74B Mar 19, 2026
FY2025 Feb 1, 2025 $2.53B Mar 19, 2026
FY2024 Feb 3, 2024 $2.29B Mar 20, 2025
FY2023 Jan 28, 2023 $1.96B Mar 21, 2024
FY2022 Jan 29, 2022 $1.76B Mar 16, 2023
FY2021 Jan 30, 2021 $1.43B Mar 30, 2022
FY2020 Feb 1, 2020 $1.20B Mar 18, 2021
FY2019 Feb 3, 2019 $955.02M Mar 19, 2020
FY2019 Feb 2, 2019 $337.17M Mar 19, 2020
FY2018 Feb 3, 2018 $237.15M Mar 28, 2019

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $2.19B Mar 19, 2026
FY2025 Feb 1, 2025 $1.81B Mar 19, 2026
FY2025 Feb 3, 2024 $1.58B Mar 19, 2026
FY2025 Jan 28, 2023 $1.36B Mar 19, 2026
FY2024 Jan 29, 2022 $1.12B Mar 20, 2025
FY2023 Jan 30, 2021 $881.89M Mar 21, 2024
FY2022 Feb 1, 2020 $759.78M Mar 16, 2023
FY2019 Feb 3, 2019 $615.09M Mar 19, 2020
FY2021 Feb 2, 2019 $615.09M Mar 30, 2022
FY2020 Feb 3, 2018 $458.56M Mar 18, 2021

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $2.01B Mar 19, 2026
FY2025 Feb 1, 2025 $1.66B Mar 19, 2026
FY2024 Feb 3, 2024 $1.40B Mar 20, 2025
FY2023 Jan 28, 2023 $1.10B Mar 21, 2024
FY2022 Jan 29, 2022 $839.06M Mar 16, 2023
FY2021 Jan 30, 2021 $560.25M Mar 30, 2022
FY2020 Feb 1, 2020 $436.89M Mar 18, 2021
FY2019 Feb 2, 2019 $261.84M Mar 19, 2020
FY2018 Feb 3, 2018 $111.70M Mar 28, 2019
FY2016 Jan 28, 2017 $9.25M Mar 22, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2019 Feb 1, 2020 $202.49M Mar 19, 2020
FY2018 Feb 2, 2019 $251.75M Mar 28, 2019
FY2018 Feb 3, 2018 $112.67M Mar 28, 2019
FY2018 Jan 28, 2017 $76.09M Mar 28, 2019
FY2018 Jan 30, 2016 $53.08M Mar 28, 2019
FY2016 Jan 31, 2015 $63.19M Mar 22, 2018
FY2016 Feb 1, 2014 $50.18M Mar 23, 2017
FY2015 Feb 2, 2013 $56.08M Mar 24, 2016
FY2014 Jan 28, 2012 $41.29M Mar 26, 2015
FY2013 Jan 29, 2011 $12.15M Mar 26, 2014

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 6 Mar 19, 2026
FY2024 Feb 1, 2025 3 Mar 20, 2025
FY2024 Nov 2, 2024 0 Mar 20, 2025
FY2024 Aug 3, 2024 0 Mar 20, 2025
FY2024 May 4, 2024 0 Mar 20, 2025
FY2024 Feb 3, 2024 3 Mar 20, 2025
FY2024 Oct 28, 2023 0 Mar 20, 2025
FY2024 Jul 29, 2023 0 Mar 20, 2025
FY2024 Apr 29, 2023 0 Mar 20, 2025
FY2023 Jan 28, 2023 3 Mar 21, 2024

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 6 Mar 19, 2026
FY2024 Feb 1, 2025 3 Mar 20, 2025
FY2024 Nov 2, 2024 0 Mar 20, 2025
FY2024 Aug 3, 2024 0 Mar 20, 2025
FY2024 May 4, 2024 0 Mar 20, 2025
FY2024 Feb 3, 2024 3 Mar 20, 2025
FY2024 Oct 28, 2023 0 Mar 20, 2025
FY2024 Jul 29, 2023 0 Mar 20, 2025
FY2024 Apr 29, 2023 0 Mar 20, 2025
FY2023 Jan 28, 2023 3 Mar 21, 2024

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 55.23M Mar 19, 2026
FY2025 Feb 1, 2025 55.03M Mar 19, 2026
FY2024 Feb 3, 2024 55.20M Mar 20, 2025
FY2023 Jan 28, 2023 55.54M Mar 21, 2024
FY2022 Jan 29, 2022 55.66M Mar 16, 2023
FY2021 Jan 30, 2021 55.94M Mar 30, 2022
FY2020 Feb 1, 2020 55.71M Mar 18, 2021
FY2019 Feb 2, 2019 55.76M Mar 19, 2020
FY2018 Feb 3, 2018 55.44M Mar 28, 2019
FY2016 Jan 28, 2017 54.90M Mar 22, 2018